OR52E5

Across TCGA pan-cancer cohorts, OR52E5 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR52E5’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where OR52E5 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR52E5 is over-expressed in tumor.

BRCA and LUSC are the cancer types where OR52E5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR52E5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	II,III,IV	+0.023	.001	2	view →
LUSC	All	All	+0.016	.019	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

OR52E5–BRCA

Open the BRCA breakdown →